ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latinoamérica

Background: There is an urgent need to assess the impact, on the incidence of neural tube defects, of the recently implanted flour fortification with folic acid in Chile. The Collaborative Study of Congenital Malformations in Latin America (ECLAMC) has carried out an uninterrupted register of congen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nazer H,Julio, López-Camelo,Jorge, Castilla,Eduardo E
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2001
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000500009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872001000500009
record_format dspace
spelling oai:scielo:S0034-988720010005000092005-11-24ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en LatinoaméricaNazer H,JulioLópez-Camelo,JorgeCastilla,Eduardo E Abnormalities Genetics, medical Neural tube defects Background: There is an urgent need to assess the impact, on the incidence of neural tube defects, of the recently implanted flour fortification with folic acid in Chile. The Collaborative Study of Congenital Malformations in Latin America (ECLAMC) has carried out an uninterrupted register of congenital malformations in the last thirty years Aim: To assess the epidemiology of neural tube defects in Chile and determine the most adequate base period to evaluate the effects of Folic acid fortification. Material and methods: analysis of ECLAMC database that has registered all births over 500 g from 1967. Results: From 1967 to 1999, there were 434.624 births in 18 hospitals in Chile and 3.586.569 births in 155 hospitals in the rest of Latin America. The rate of neural tube defects in Chile was 17.03 per 10.000, significantly higher than the rest of ECLAMC (14.88 per 10.000). The prevalence of neural tube defects has a statistically significant secular tendency to increase in the study period and is higher among stillbirths, newborns with a birth weight of less than 1500 g, women and offspring of mothers aged less than 19 years old. Conclusions: The period 1982-1999 is considered the best period for reference comparisons of the effects folic acid supplementation (Rev Méd Chile 2001; 129: 531-9)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.129 n.5 20012001-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000500009es10.4067/S0034-98872001000500009
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Abnormalities
Genetics, medical
Neural tube defects
spellingShingle Abnormalities
Genetics, medical
Neural tube defects
Nazer H,Julio
López-Camelo,Jorge
Castilla,Eduardo E
ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latinoamérica
description Background: There is an urgent need to assess the impact, on the incidence of neural tube defects, of the recently implanted flour fortification with folic acid in Chile. The Collaborative Study of Congenital Malformations in Latin America (ECLAMC) has carried out an uninterrupted register of congenital malformations in the last thirty years Aim: To assess the epidemiology of neural tube defects in Chile and determine the most adequate base period to evaluate the effects of Folic acid fortification. Material and methods: analysis of ECLAMC database that has registered all births over 500 g from 1967. Results: From 1967 to 1999, there were 434.624 births in 18 hospitals in Chile and 3.586.569 births in 155 hospitals in the rest of Latin America. The rate of neural tube defects in Chile was 17.03 per 10.000, significantly higher than the rest of ECLAMC (14.88 per 10.000). The prevalence of neural tube defects has a statistically significant secular tendency to increase in the study period and is higher among stillbirths, newborns with a birth weight of less than 1500 g, women and offspring of mothers aged less than 19 years old. Conclusions: The period 1982-1999 is considered the best period for reference comparisons of the effects folic acid supplementation (Rev Méd Chile 2001; 129: 531-9)
author Nazer H,Julio
López-Camelo,Jorge
Castilla,Eduardo E
author_facet Nazer H,Julio
López-Camelo,Jorge
Castilla,Eduardo E
author_sort Nazer H,Julio
title ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latinoamérica
title_short ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latinoamérica
title_full ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latinoamérica
title_fullStr ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latinoamérica
title_full_unstemmed ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latinoamérica
title_sort eclamc: estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en chile y en latinoamérica
publisher Sociedad Médica de Santiago
publishDate 2001
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000500009
work_keys_str_mv AT nazerhjulio eclamcestudiode30anosdevigilanciaepidemiologicadedefectosdetuboneuralenchileyenlatinoamerica
AT lopezcamelojorge eclamcestudiode30anosdevigilanciaepidemiologicadedefectosdetuboneuralenchileyenlatinoamerica
AT castillaeduardoe eclamcestudiode30anosdevigilanciaepidemiologicadedefectosdetuboneuralenchileyenlatinoamerica
_version_ 1718435971447390208